95 related articles for article (PubMed ID: 10403552)
1. Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro.
Hosoya Y; Kitoh Y; Kobayashi E; Okabe R; Fujimura A; Kanazawa K
Cancer Lett; 1999 Jun; 140(1-2):139-43. PubMed ID: 10403552
[TBL] [Abstract][Full Text] [Related]
2. Brief tamoxifen pretreatment enhances the chemosensitivity of gastric carcinoma cells to 5-fluorouracil in vitro.
Koullias GJ; Pratsinis CI; Korkolis DP; Kouraklis G; Papadopoulos SA; Davaris PS; Golematis BCh
Anticancer Res; 2003; 23(2B):1575-80. PubMed ID: 12820425
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen enhances the cytotoxicity of conventional chemotherapy in esophageal adenocarcinoma cells.
Due SL; Watson DI; Bastian I; Ding GQ; Sukocheva OA; Astill DS; Vat L; Hussey DJ
Surg Oncol; 2016 Sep; 25(3):269-77. PubMed ID: 27566033
[TBL] [Abstract][Full Text] [Related]
4. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.
Gao K; Liang Q; Zhao ZH; Li YF; Wang SF
World J Gastroenterol; 2016 Mar; 22(10):2971-80. PubMed ID: 26973393
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
7. In vitro combination effect of 5-fluorouracil and cisplatin on the proliferation, morphology and expression of Ki-67 antigen in human gastric cancer cells.
Imada T; Rino Y; Takahashi M; Amano T; Kusada O; Kitaura K
Anticancer Drugs; 1997 Nov; 8(10):1000-6. PubMed ID: 9436643
[TBL] [Abstract][Full Text] [Related]
8. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
9. Oestradiol and tamoxifen inhibit murine Colon 38 cancer growth and increase the cytotoxic effect of fluorouracil.
Motylewska E; Lawnicka H; Mełeń-Mucha G
Endokrynol Pol; 2007; 58(5):426-34. PubMed ID: 18058739
[TBL] [Abstract][Full Text] [Related]
10. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
11. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Int J Oncol; 2004 Apr; 24(4):807-13. PubMed ID: 15010816
[TBL] [Abstract][Full Text] [Related]
13. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
14. Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.
Yasuda C; Kato M; Kuroda D; Ohyanagi H
Jpn J Cancer Res; 1997 Jan; 88(1):97-102. PubMed ID: 9045902
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
17. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture.
Aizawa K; Muto I; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Katayanagi N; Suzuki T; Tanaka O; Muto T
Surg Today; 1994; 24(5):420-8. PubMed ID: 8054813
[TBL] [Abstract][Full Text] [Related]
19. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells.
Hochner-Celnikier D; Greenfield C; Finci-Yeheskel Z; Milwidsky A; Gutman A; Goldman-Wohl D; Yagel S; Mayer M
Mol Hum Reprod; 1997 Dec; 3(12):1019-27. PubMed ID: 9464846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
